Skip to main content
Equibles

Bellevue Group AG

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1674546 Zurich, V8
Back to BBIO Full portfolio

Position in BBIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$88,594,406
+$86,709,910 QoQ
Shares Held
1,189,506
+4587.3% QoQ
Ownership
0.608%
of shares outstanding
% of Portfolio
1.92%
of 13F equity value
Holder Rank
#41
of 472 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bellevue Group AG holds $2,744,593,561 across 63 Biotechnology names. BBIO ranks #12 (3.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 578,634 $287,424,866
2 ARGX
Argenx SE
 301,000 $279,258,770
3 RVMD
Revolution Medicines, Inc.
 1,048,014 $196,272,061
4 ORKA
Oruka Therapeutics, Inc.
 1,657,190 $157,714,772
5 INSM
INSMED Inc
 1,393,418 $148,566,226
6 SRRK
Scholar Rock Holding Corp
 2,449,547 $134,725,085
7 VRDN
Viridian Therapeutics, Inc.\DE
 6,731,909 $123,665,167
8 RLAY
Relay Therapeutics, Inc.
 6,185,970 $115,739,498

All Filings in BBIO

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $88,594,406 1,189,506
2026-03-31 $1,884,496 25,377
2025-12-31 $1,844,250 24,111
2025-09-30 $1,057,290 20,356
2025-06-30 $449,072 10,400
2025-03-31 $359,528 10,400
2024-12-31 $285,376 10,400
2024-09-30 $264,784 10,400
2024-06-30 $324,224 12,800
2024-03-31 $395,776 12,800
2023-12-31 $1,344,321 33,300
2023-09-30 $2,075,319 78,700
2023-06-30 $1,666,680 96,900
2023-03-31 $1,369,508 82,600